Interestingly, in another study, there was a numerical trend towards a higher 30-day mortality among patients who underwent redo-TAVR for procedural versus THV failure, but this was not statistically significant (5.4% versus 1.4%, respectively; p=0.427).[ 8 ] Periprocedural complications were low, and the 30-day survival was 94.6% in those undergoing redo-TAVR for procedural failure and 98.5% in those with THV failure (p=0.101).
← all excerpts
Redo-Transcatheter Aortic Valve Replacement: Strategies When the First Transcatheter Aortic Valve Replacement Fails.
1
—
—